Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Stock
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+73.3K
-
Total reported value, excl. options
-
$90.7M
-
Value change
-
+$923K
-
Number of buys
-
15
-
Number of sells
-
-22
-
Price
-
$8.10
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q3 2017
54 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q3 2017.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
.
Largest 10 shareholders include FMR LLC (1.47M shares), INTERWEST VENTURE MANAGEMENT CO (1.36M shares), BB BIOTECH AG (1.34M shares), FRAZIER MANAGEMENT LLC (1.31M shares), Aisling Capital LLC (1.02M shares), Broadfin Capital, LLC (820K shares), MILLENNIUM MANAGEMENT LLC (605K shares), VANGUARD GROUP INC (553K shares), Omega Fund Management, LLC (445K shares), and Rock Springs Capital Management LP (300K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.